Cell-type-specific activation of the oligoadenylate synthetase-rnase l pathway by a murine coronavirus

Journal of Virology

Volumn 87, Issue 15, 2013, Pages 8408-8418

  Zhao, Ling ^a,e   Birdwell, Dillon ^a   Wu, Ashley ^a   Elliott, Ruth ^a   Rose, Kristine M ^a   Phillips, Judith M ^a   Li, Yize ^a   Grinspan, Judith ^b,c   Silverman, Robert H ^d   Weiss, Susan R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; MESSENGER RNA; OLIGOADENYLATE SYNTHETASE; PHOSPHODIESTERASE; RIBONUCLEASE L; RIBOSOME RNA; SYNTHETASE; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; BRAIN CELL; CELL KINETICS; CELL LEVEL; CELL LINEAGE; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME INACTIVATION; ENZYME LOCALIZATION; GENE EXPRESSION; GENE LOCATION; LIVER CELL; LIVER PARENCHYMA; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; OLIGOADENYLATE SYNTHETASE GENE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA CLEAVAGE; SIGNAL TRANSDUCTION; VIRUS GENE; VIRUS REPLICATION; VIRUS STRAIN;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; CELLS, CULTURED; ENDORIBONUCLEASES; GENE DELETION; HOST-PATHOGEN INTERACTIONS; MICE; MICE, INBRED C57BL; MURINE HEPATITIS VIRUS; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84880640767     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00769-13     Document Type: Article

References (57)

1. Navas S, Weiss SR. 2003. Murine coronavirus-induced hepatitis: JHM genetic background eliminates A59 spike-determined hepatotropism. J. Virol. 77:4972-4978.
2. Zhao L, Rose KM, Elliott R, Van Rooijen N, Weiss SR. 2011. Cell-typespecific type I interferon antagonism influences organ tropism of murine coronavirus. J. Virol. 85:10058-10068.
3. Roth-Cross JK, Bender SJ, Weiss SR. 2008. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J. Virol. 82:9829-9838.
4. Ireland DD, Stohlman SA, Hinton DR, Atkinson R, Bergmann CC. 2008. Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J. Virol. 82:300-310.
5. Cervantes-Barragan L, Zust R, Weber F, Spiegel M, Lang KS, Akira S, Thiel V, Ludewig B. 2007. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109:1131-1137.
6. Dong B, Silverman RH. 1995. 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J. Biol. Chem. 270:4133-4137.
7. Malathi K, Dong B, Gale M, Jr, Silverman RH. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: 816-819.
8. Silverman RH. 2007. Viral encounters with 2=,5=-oligoadenylate synthetase and RNase L during the interferon antiviral response. J. Virol. 81: 12720-12729.
9. Zhou A, Paranjape J, Brown TL, Nie H, Naik S, Dong B, Chang A, Trapp B, Fairchild R, Colmenares C, Silverman RH. 1997. Interferon action and apoptosis are defective in mice devoid of 2=,5=-oligoadenylatedependent RNase L. EMBO J. 16:6355-6363.
10. Randall RE, Goodbourn S. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89:1-47.
11. Zhao L, Jha BK, Wu A, Elliott R, Ziebuhr J, Gorbalenya AE, Silverman RH, Weiss SR. 2012. Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe 11:607-616.
12. Roth-Cross JK, Stokes H, Chang G, Chua MM, Thiel V, Weiss SR, Gorbalenya AE, Siddell SG. 2009. Organ-specific attenuation of murine hepatitis virus strain A59 by replacement of catalytic residues in the putative viral cyclic phosphodiesterase ns2. J. Virol. 83:3743-3753.
13. Gombold JL, Hingley ST, Weiss SR. 1993. Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J. Virol. 67:4504-4512.
14. Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Muhlberger E, Bray M, Klenk HD, Palese P, Garcia-Sastre A. 2003. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 77:7945-7956.
15. Thompson WH, Kalfayan B, Anslow RO. 1965. Isolation of California Encephalitis Group Virus from a fatal human illness. Am. J. Epidemiol. 81:245-253.
16. Hoskins JM, Sanders FK. 1957. Propagation of mouse encephalomyocarditis virus in ascites tumour cells maintained in vitro. Br. J. Exp. Pathol. 38:268-272.
17. Park MS, Shaw ML, Munoz-Jordan J, Cros JF, Nakaya T, Bouvier N, Palese P, Garcia-Sastre A, Basler CF. 2003. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for theNDVV protein and the Nipah virus V, W, and C proteins. J. Virol. 77:1501-1511.
18. Caamano J, Alexander J, Craig L, Bravo R, Hunter CA. 1999. The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J. Immunol. 163:4453-4461.
19. Bender SJ, Phillips JM, Scott EP, Weiss SR. 2010. Murine coronavirus receptors are differentially expressed in the central nervous system and play virus strain-dependent roles in neuronal spread. J. Virol. 84:11030-11044.
20. Feigenson K, Reid M, See J, Crenshaw EB, III, Grinspan JB. 2009. Wnt signaling is sufficient to perturb oligodendrocyte maturation. Mol. Cell Neurosci. 42:255-265.
21. Feigenson K, Reid M, See J, Crenshaw IE, Grinspan JB. 2011. Canonical Wnt signalling requires the BMP pathway to inhibit oligodendrocyte maturation. ASN Neuro. 3:e00061. doi:10.1042/AN20110004.
22. Xiang Y, Wang Z, Murakami J, Plummer S, Klein EA, Carpten JD, Trent JM, Isaacs WB, Casey G, Silverman RH. 2003. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2=,5=-oligoadenylates. Cancer Res. 63:6795-6801.
23. Weiss SR, Leibowitz JL. 2011. Coronavirus pathogenesis. Adv. Virus Res. 81:85-164.
24. Fensterl V, Wetzel JL, Ramachandran S, Ogino T, Stohlman SA, Bergmann CC, Diamond MS, Virgin HW, Sen GC. 2012. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog. 8:e1002712. doi:10.1371/journal.ppat.1002712.
25. Roth-Cross JK, Martinez-Sobrido L, Scott EP, Garcia-Sastre A, Weiss SR. 2007. Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels. J. Virol. 81:7189-7199.
26. Zhou A, Molinaro RJ, Malathi K, Silverman RH. 2005. Mapping of the human RNASEL promoter and expression in cancer and normal cells. J. Interferon Cytokine Res. 25:595-603.
27. Kubota K, Nakahara K, Ohtsuka T, Yoshida S, Kawaguchi J, Fujita Y, Ozeki Y, Hara A, Yoshimura C, Furukawa H, Haruyama H, Ichikawa K, Yamashita M, Matsuoka T, Iijima Y. 2004. Identification of 2=-phosphodiesterase, which plays a role in the 2-5A system regulated by interferon. J. Biol. Chem. 279:37832-37841.
28. Ida-Hosonuma M, Sasaki Y, Toyoda H, Nomoto A, Gotoh O, Yonekawa H, Koike S. 2003. Host range of poliovirus is restricted to simians because of a rapid sequence change of the poliovirus receptor gene during evolution. Arch. Virol. 148:29-44.
29. Ida-Hosonuma M, Iwasaki T, Yoshikawa T, Nagata N, Sato Y, Sata T, Yoneyama M, Fujita T, Taya C, Yonekawa H, Koike S. 2005. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J. Virol. 79:4460-4469.
30. Daffis S, Samuel MA, Keller BC, Gale M, Jr, Diamond MS. 2007. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and-independent mechanisms. PLoS Pathog. 3:e106. doi:10.1371/journal.ppat.0030106
31. Zhou H, Zhao J, Perlman S. 2010. Autocrine interferon priming in macrophages but not dendritic cells results in enhanced cytokine and chemokine production after coronavirus infection. MBio 1: pii:e00219-10. doi:10.1128/mBio.00219-10.
32. Kapil P, Butchi NB, Stohlman SA, Bergmann CC. 2012. Oligodendroglia are limited in type I interferon induction and responsiveness in vivo. Glia 60:1555-1566.
33. Daffis S, Suthar MS, Gale M, Jr, Diamond MS. 2009. Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virus. J. Innate Immun. 1:435-445.
34. Zhou H, Perlman S. 2007. Mouse hepatitis virus does not induce beta interferon synthesis and does not inhibit its induction by double-stranded RNA. J. Virol. 81:568-574.
35. Versteeg GA, Bredenbeek PJ, van den Worm SH, Spaan WJ. 2007. Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition. Virology 361:18-26.
36. Overby AK, Popov VL, Niedrig M, Weber F. 2010. Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles. J. Virol. 84:8470-8483.
37. Hagemeijer MC, Vonk AM, Monastyrska I, Rottier PJ, de Haan CA. 2012. Visualizing coronavirus RNA synthesis in time by using click chemistry. J. Virol. 86:5808-5816.
38. van den Worm SH, Knoops K, Zevenhoven-Dobbe JC, Beugeling C, van der Meer Y, Mommaas AM, Snijder EJ. 2011. Development and RNA-synthesizing activity of coronavirus replication structures in the absence of protein synthesis. J. Virol. 85:5669-5673.
39. Knoops K, Swett-Tapia C, van den Worm SH, Te Velthuis AJ, Koster AJ, Mommaas AM, Snijder EJ, Kikkert M. 2010. Integrity of the early secretory pathway promotes, but is not required for, severe acute respiratory syndrome coronavirus RNA synthesis and virus-induced remodeling of endoplasmic reticulum membranes. J. Virol. 84:833-846.
40. van Hemert MJ, van den Worm SH, Knoops K, Mommaas AM, Gorbalenya AE, Snijder EJ. 2008. SARS-coronavirus replication/ transcription complexes are membrane-protected and need a host factor for activity in vitro. PLoS Pathog. 4:e1000054. doi:10.1371/journal.ppat .1000054.
41. Prentice E, McAuliffe J, Lu X, Subbarao K, Denison MR. 2004. Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins. J. Virol. 78:9977-9986.
42. Cho H, Proll SC, Szretter KJ, Katze MG, Gale M, Jr, Diamond MS. 2013. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positivestranded RNA viruses. Nat. Med. 19:458-464.
43. Crispe IN. 2009. The liver as a lymphoid organ. Annu. Rev. Immunol. 27:147-163.
44. Cervantes-Barragan L, Kalinke U, Zust R, Konig M, Reizis B, Lopez-Macias C, Thiel V, Ludewig B. 2009. Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection. J. Immunol. 182:1099-1106.
45. Lang PA, Recher M, Honke N, Scheu S, Borkens S, Gailus N, Krings C, Meryk A, Kulawik A, Cervantes-Barragan L, Van Rooijen N, Kalinke U, Ludewig B, Hengartner H, Harris N, Haussinger D, Ohashi PS, Zinkernagel RM, Lang KS. 2010. Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology 52:25-32.
46. Asada-Kubota M, Tatsumi R, Ueda T, Kobayashi M, Hamada K, Maekawa S, Sokawa Y. 1998. The target cells of injected type I interferons in mouse liver. J. Interferon Cytokine Res. 18:71-74
47. Stephenson JB. 2008. Aicardi-Goutieres syndrome (AGS). Eur. J. Paediatr. Neurol. 12:355-358.
48. Paul S, Ricour C, Sommereyns C, Sorgeloos F, Michiels T. 2007. Type I interferon response in the central nervous system. Biochimie 89:770-778.
49. Castelli JC, Hassel BA, Maran A, Paranjape J, Hewitt JA, Li XL, Hsu YT, Silverman RH, Youle RJ. 1998. The role of 2=-5= oligoadenylate-activated ribonuclease L in apoptosis. Cell Death Differ. 5:313-320.
50. Miura TA, Travanty EA, Oko L, Bielefeldt-Ohmann H, Weiss SR, Beauchemin N, Holmes KV. 2008. The spike glycoprotein of murine coronavirus MHV-JHM mediates receptor-independent infection and spread in the central nervous systems of Ceacam1a-/-mice. J. Virol. 82:755-763.
51. Rose KM, Elliott R, Martinez-Sobrido L, Garcia-Sastre A, Weiss SR. 2010. Murine coronavirus delays expression of a subset of interferonstimulated genes. J. Virol. 84:5656-5669.
52. Rose KM, Weiss SR. 2009. Murine coronavirus cell type dependent interaction with the type I interferon response. Viruses 1:689-712.
53. Phillips JJ, Chua MM, Rall GF, Weiss SR. 2002. Murine coronavirus spike glycoprotein mediates degree of viral spread, inflammation, and virus-induced immunopathology in the central nervous system. Virology 301:109-120.
54. Asada-Kubota M, Ueda T, Nakashima T, Kobayashi M, Shimada M, Takeda K, Hamada K, Maekawa S, Sokawa Y. 1997. Localization of 2=,5=-oligoadenylate synthetase and the enhancement of its activity with recombinant interferon-alpha A/D in the mouse brain. Anat. Embryol. 195:251-257.
55. Ireland DD, Stohlman SA, Hinton DR, Kapil P, Silverman RH, Atkinson RA, Bergmann CC. 2009. RNase L mediated protection from virus induced demyelination. PLoS Pathog. 5:e1000602. doi:10.1371/journal .ppat.1000602.
56. Cowan CM, Roskams AJ. 2002. Apoptosis in the mature and developing olfactory neuroepithelium. Microsc. Res. Tech. 58:204-215.
57. Detje CN, Meyer T, Schmidt H, Kreuz D, Rose JK, Bechmann I, Prinz M, Kalinke U. 2009. Local type I IFN receptor signaling protects against virus spread within the central nervous system. J. Immunol. 182:2297-2304.